Cherqui G, Caron M, Capeau J, Picard J
Biochem J. 1983 Jul 15;214(1):111-20. doi: 10.1042/bj2140111.
Lectins specific for D-mannose (concanavalin A), N-acetyl-D-glucosamine (wheat-germ agglutinin) or D-galactose (Ricinus communis agglutinin I) inhibited insulin binding and activated glucose transport in rat adipocytes [Cherqui, Caron, Capeau & Picard (1982) Mol. Cell. Endocrinol. 28, 627-643]. In the present investigation, the intracellular activities of insulin and lectins on lipogenesis and protein synthesis were studied under conditions where neither agent had an effect on membrane transport processes. (1) When glucose transport was rate-limiting (0.5 mM-glucose), insulin (0.8 ng/ml) and lectins (20 micrograms/ml) increased lipogenesis by 2.4-3-fold. (2) When passive diffusion of glucose was amplified (10 mM-glucose), insulin (0.8 ng/ml) and lectins (20 micrograms/ml) increased lipogenesis by 1.6-1.8-fold even in the presence of 50 microM-cytochalasin B, which completely blocked glucose transport. (3) Insulin (6 ng/ml), concanavalin A and wheat-germ agglutinin (40 micrograms/ml) stimulated the incorporation of L-[U-14C]leucine into fat-cell protein 1.5-fold but did not modify alpha-aminoisobutyric acid uptake or 14C-labelled protein degradation. (4) Peanut and soya-bean agglutinins (specific for O-glycosidically-linked oligosaccharides), known not to alter insulin binding, were ineffective. (5) Lectin effects were dose-dependent and were markedly inhibited by specific monosaccharides (50 mM). (6) Insulin and lectin maximal effects were not additive and were completely abolished by neuraminidase treatment of fat-cells (0.05 unit/ml). These data indicate involvement of surface sialylated glycoproteins of the complex N-linked type in the insulin stimulation of glucose and amino acid intracellular metabolic processes. They suggest, together with our previous results, that the transmission of the insulin signal for both membrane and intracellular effects occurs via glycosylated effector entities of, or closely linked to, the insulin-receptor complex.
对D-甘露糖具有特异性的凝集素(伴刀豆球蛋白A)、N-乙酰-D-葡糖胺(麦胚凝集素)或D-半乳糖(蓖麻凝集素I)可抑制大鼠脂肪细胞中的胰岛素结合并激活葡萄糖转运[Cherqui、Caron、Capeau和Picard(1982年)《分子与细胞内分泌学》28卷,627 - 643页]。在本研究中,在两种试剂均不影响膜转运过程的条件下,研究了胰岛素和凝集素对脂肪生成和蛋白质合成的细胞内活性。(1)当葡萄糖转运成为限速因素时(0.5 mM葡萄糖),胰岛素(0.8 ng/ml)和凝集素(20 μg/ml)使脂肪生成增加2.4至3倍。(2)当葡萄糖的被动扩散增强时(10 mM葡萄糖),即使存在50 μM细胞松弛素B(它完全阻断葡萄糖转运),胰岛素(0.8 ng/ml)和凝集素(20 μg/ml)仍使脂肪生成增加1.6至1.8倍。(3)胰岛素(6 ng/ml)、伴刀豆球蛋白A和麦胚凝集素(40 μg/ml)刺激L-[U-¹⁴C]亮氨酸掺入脂肪细胞蛋白质的量增加1.5倍,但未改变α-氨基异丁酸摄取或¹⁴C标记蛋白质的降解。(4)已知对O-糖苷键连接的寡糖具有特异性的花生凝集素和大豆凝集素不改变胰岛素结合,它们没有效果。(5)凝集素的作用呈剂量依赖性,并且被特异性单糖(50 mM)显著抑制。(6)胰岛素和凝集素的最大作用不是相加的,并且用神经氨酸酶处理脂肪细胞(0.05单位/ml)可使其完全消除。这些数据表明复杂N-连接型的表面唾液酸化糖蛋白参与胰岛素对葡萄糖和氨基酸细胞内代谢过程的刺激作用。它们与我们先前的结果一起表明,胰岛素信号对于膜和细胞内效应的传递是通过胰岛素受体复合物的糖基化效应实体或与之紧密相连的实体发生的。